A Pure Marijuana Play For A Growing Market

TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Today I’m going to look at one of the most intriguing cannabis stocks I’ve found so far.

That company is Canopy Growth Corp. (TSE: WEED) (TWMJF), and it has become a massive player in Canada’s booming medical marijuana industry.

Canopy is a vertically integrated cannabis company. It does it all: grow, process, market and distribute. It’s as “pure” of a play on cannabis as you’ll find.

Canopy is expected to produce revenue of $44.8 million in fiscal 2017, up roughly 180% from 2016. The company is not yet profitable, but that hasn’t stopped enthusiastic investors from pushing the company’s share price up from a 52-week low of $2.40 to $11.05 as of March 16, 2017. (Note: All financial numbers are in Canadian dollars.)

The company’s market capitalization has risen to an impressive $1.7 billion. And in a vote of confidence, its shares were recently added to the S&P TSX Composite Index, Canada’s benchmark stock index.

Canopy operates out of an abandoned Hershey factory in Ontario, which it purchased for the bargain price of $6.6 million. This is a massive facility with more than 500,000 square feet of space.

Canada’s Plan to End Marijuana Prohibition

As you can see, Canopy’s medical marijuana business is humming along nicely. But the real potential comes as early as next year, when Canada is expected to legalize pot for recreational use.

A study by Deloitte estimates that Canada’s retail marijuana sales could grow to $8.7 billion annually as a result.

And when you factor in the entire market (growing, processing and testing), that number could grow to a massive $22.6 billion per year.

Canopy is positioned nicely to take advantage of this shift. The company is well-capitalized, with more than $90 million in cash and just $7 million in debt.